Abstract
Ancient societies had no rational understanding of fever. The Greeks were the first to recognise that it may be part of nature's method of effecting cure in some diseases. How best to assist nature went through many trials and errors. Appreciation of the prognostic value of fever and how it may be controlled was slow to appear. That there was a place in the therapeutic arsenal for induced fever came only with the 20th century. Finding a suitable, safe, and satisfactory means came slowly. The curative power of well controlled and reproducible levels of fever was proved by the arrest of one deadly and incurable complication of a sexually transmitted disease in the first half of this century. The purpose of this review is to promote discussion and, hopefully, well ordered laboratory and clinical trials aimed at learning whether or not induced fevers have a place in the care of patients with HIV/AIDS.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alonso K., Pontiggia P., Sabato A., Calvi G., Curto F. C., de Bartolomei E., Nardi C., Cereda P. Systemic hyperthermia in the treatment of HIV-related disseminated Kaposi's sarcoma. Long-term follow-up of patients treated with low-flow extracorporeal perfusion hyperthermia. Am J Clin Oncol. 1994 Aug;17(4):353–359. doi: 10.1097/00000421-199408000-00015. [DOI] [PubMed] [Google Scholar]
- Jezová D., Kvetnanský R., Vigas M. Sex differences in endocrine response to hyperthermia in sauna. Acta Physiol Scand. 1994 Mar;150(3):293–298. doi: 10.1111/j.1748-1716.1994.tb09689.x. [DOI] [PubMed] [Google Scholar]
- Levy J. A. HIV research: a need to focus on the right target. Lancet. 1995 Jun 24;345(8965):1619–1621. doi: 10.1016/s0140-6736(95)90121-3. [DOI] [PubMed] [Google Scholar]
- Morita M., Suzuki T., Nakajima K., Shiozawa C., Gill M. J., Hoshino H. Characteristics and clinical significance of a stabilization assay to detect specific antibodies to reverse transcriptase of human immunodeficiency virus. Clin Diagn Lab Immunol. 1995 Sep;2(5):583–589. doi: 10.1128/cdli.2.5.583-589.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nowak T., Niedrig M., Bernhardt D., Hilfenhaus J. Inactivation of HIV, HBV, HCV related viruses and other viruses in human plasma derivatives by pasteurisation. Dev Biol Stand. 1993;81:169–176. [PubMed] [Google Scholar]
- Orloff S. L., Wallingford J. C., McDougal J. S. Inactivation of human immunodeficiency virus type I in human milk: effects of intrinsic factors in human milk and of pasteurization. J Hum Lact. 1993 Mar;9(1):13–17. doi: 10.1177/089033449300900125. [DOI] [PubMed] [Google Scholar]
- Pennypacker C., Perelson A. S., Nys N., Nelson G., Sessler D. I. Localized or systemic in vivo heat inactivation of human immunodeficiency virus (HIV): a mathematical analysis. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):321–329. [PubMed] [Google Scholar]
- Steinhart C. R., Ash S. R., Gingrich C., Sapir D., Keeling G. N., Yatvin M. B. Effect of whole-body hyperthermia on AIDS patients with Kaposi's sarcoma: a pilot study. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Mar 1;11(3):271–281. doi: 10.1097/00042560-199603010-00007. [DOI] [PubMed] [Google Scholar]
- Tjøtta E., Hungnes O., Grinde B. Survival of HIV-1 activity after disinfection, temperature and pH changes, or drying. J Med Virol. 1991 Dec;35(4):223–227. doi: 10.1002/jmv.1890350402. [DOI] [PubMed] [Google Scholar]
- WOOD W. B., Jr Studies on the cause of fever. N Engl J Med. 1958 May 22;258(21):1023–1031. doi: 10.1056/NEJM195805222582101. [DOI] [PubMed] [Google Scholar]